Patch Based Delivery
Not Specified
Proof of Concept/Bench ValidationActive
Key Facts
Indication
Not Specified
Phase
Proof of Concept/Bench Validation
Status
Active
Company
About Hera Health Solutions
Hera Health Solutions is a private, pre-revenue biotech firm developing a tunable nanofiber-based drug delivery platform capable of sustained release from days to years. The company is advancing a pipeline of long-acting subcutaneous implants and patches, primarily in women's health and substance use disorder, through internal programs and co-development/licensing partnerships. Its strategy is to collaborate with pharmaceutical companies to reformulate existing APIs, leveraging FDA/GMP-approved materials and manufacturing for a potentially streamlined regulatory path.
View full company profileTherapeutic Areas
Other Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |